visualvisitorlogo
  • Our Platform downarrow
    Powerful Sales
    Intelligence     dashboard
    Platform Overview
    Buyer Intent Data
    B2B Prospect Data     Website Visitor ID Email Tracking
  • Why?downarrow
    Your Challenges Our Data See For Yourself
  • Pricing
  • Resourcesdownarrow
    Resellers
    Add Onsdrop
    Call Tracking     Keyword Level Tracking Reputation Management
    Integrations About Us
    Contactdrop
    Atlanta Jacksonville
    Blog Careers Support
    • Login Free Trial Schedule A Demo
    × Our Platform downarrow
    Why? downarrow
    Pricing Resources downarrow
    visualvisitorlogo ☰

    Arrakis Therapeutics

    Get Full Access

    Description

    • Arrakis Therapeutics is a biopharmaceutical company pioneering the discovery of a new class of medicines that directly target RNA. The companys TRYST and PEARL-seq platforms identify new RNA targets and drug candidates to treat diseases unaddressed by todays medicines. Arrakis is developing a proprietary pipeline of RNA-targeted small molecules focused on neurologic diseases, cancer, and rare genetic diseases. Arrakis was founded in 2015 by Russell Petter, Ph.D., Alan Walts, Ph.D., Henri Termeer and Raj Parekh, Ph.D. with a vision to create a proprietary, transformational discovery platform that identifies small-molecule drugs that act directly on disease-causing RNA. The company was established with seed funding provided by Advent Life Sciences and Henri Termeer. The company brings together scientific leaders in RNA structure, chemistry and biology, along with a highly experienced management team and the backing of leading life sciences investors. The company is located in Waltham, Mass.
    • location

      Headquarters:35 Gatehouse Drive , Waltham, Massachusetts, United States

      More
    • Arrakis Therapeutics phone

      Phone Number: +1 617-913-0348

    • Arrakis Therapeutics website

      Website: https://www.arrakistx.com

    • Arrakis Therapeutics employees

      Employees:71

    • Arrakis Therapeutics revenue

      Revenue:$10 - 50M

    • Arrakis Therapeutics legal name

      Legal Name:Arrakis Therapeutics

    • Arrakis Therapeutics's Social Media

      Arrakis Therapeutics linkedin Arrakis Therapeutics twitter
    • done Is this data correct?

    • |  NAICS Code: 325412  |

      Show More
    Person level website identification

    CEO for Arrakis Therapeutics

    Michael Gilman

    Chief Executive Officer

    Person level website visitor identification

    Sell more in less time!

    Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!

    View Employees

    Jacques Dumas

    Chief Scientific Officer

    James Mutamba

    Chief Business Officer

    Jennifer Petter

    Arrakis Therapeutics, Founder And Chief Information Officer

    Katrine Bosley

    Chairman Of The Board

    Patrizio Renzetti

    Vice President Human Resources

    Frequently Asked Questions regarding Arrakis Therapeutics

    • Where are Arrakis Therapeutics's Headquarters?

      Arrakis Therapeutics's Headquarters are in 35 Gatehouse Drive ,Waltham,Massachusetts,United States

    • What is Arrakis Therapeutics's phone number?

      Arrakis Therapeutics's phone number is +1 617-913-0348

    • What is Arrakis Therapeutics's official website?

      Arrakis Therapeutics's official website is https://www.arrakistx.com

    • What is Arrakis Therapeutics's Revenue?

      Arrakis Therapeutics's revenue is $10 - 50M

    • What is Arrakis Therapeutics's NAICS code?

      Arrakis Therapeutics's NAICS code is 325412

    • How many employees are working in Arrakis Therapeutics

      Arrakis Therapeutics has 71 employees

    • What is Arrakis Therapeutics's Industry?

      Arrakis Therapeutics is in the industry of Pharmaceuticals

    • Who is Arrakis Therapeutics's CEO?

      Arrakis Therapeutics's CEO is Michael Gilman

    Company Directory